Cardiff Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2009
Net Income	-41.47	-38.73	-28.32	-22.6	-16.71	-19.25	-24.93	-39.23	-27.5	-14.35	Upgrade
Depreciation & Amortization	0.4	0.24	0.45	0.47	0.49	0.86	1.25	1.07	0.38	0.23	Upgrade
Share-Based Compensation	4.51	4.26	3.23	1.77	0.88	2.17	4.01	7.5	3.95	2.07	Upgrade
Other Operating Activities	5.65	0.39	1.57	0.76	1.77	0.23	-3.63	-0.41	1.03	-0.71	Upgrade
Operating Cash Flow	-30.89	-33.82	-23.04	-16.32	-13.27	-13.2	-23.28	-31.04	-22.12	-12.73	Upgrade
Capital Expenditures	-0.58	-1.01	-0.21	-0.21	-0.07	0.02	-0.1	-0.82	-2.23	-0.3	Upgrade
Change in Investments	36.78	39.04	-131.24	0	0	0	24.06	-24.01	0	0	Upgrade
Other Investing Activities	-	0.11	-	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	36.2	38.15	-131.45	-0.21	-0.07	0.02	23.96	-24.83	-2.23	-0.3	Upgrade
Share Issuance / Repurchase	0	0.08	35.45	137.32	12.12	13.39	10.86	2.65	63.47	0	Upgrade
Debt Issued / Paid	0	0	0	0	0	-1.38	-17.24	-0.35	1.09	14.48	Upgrade
Other Financing Activities	-	-	-	-0.01	-0.04	4.39	-	-	-	-	Upgrade
Financing Cash Flow	0	0.08	35.45	137.31	12.08	16.4	-6.38	2.3	64.55	14.48	Upgrade
Exchange Rate Effect	0	0	0	0	0	0	0.01	-0.01	0	0	Upgrade
Net Cash Flow	5.31	4.4	-119.04	120.79	-1.26	3.23	-5.69	-53.58	40.2	1.46	Upgrade
Free Cash Flow	-31.47	-34.83	-23.25	-16.53	-13.34	-13.18	-23.38	-31.86	-24.35	-13.03	Upgrade
Free Cash Flow Margin	-6448.57%	-9022.28%	-6474.93%	-4515.30%	-5451.09%	-3482.77%	-4626.13%	-8361.50%	-7785.02%	-4649.61%	Upgrade
Free Cash Flow Per Share	-0.70	-0.80	-0.60	-0.79	-2.23	-5.66	-48.54	-76.03	-66.92	-49.62	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).